The Legal Examiner Affiliate Network The Legal Examiner The Legal Examiner The Legal Examiner search instagram avvo phone envelope checkmark mail-reply spinner error close The Legal Examiner The Legal Examiner The Legal Examiner
Skip to main content

Accutane side effects and injuries have prompted 6,634 people to file an Accutane lawsuit in New Jersey against the manufacturer of the controversial acne drug, Hoffman-LaRoche.

A master complaint was filed as more plaintiffs joined the Accutane mass tort lawsuit. The purpose of the master complaint is to centralize the plaintiffs’ common allegations, which include Accutane Crohns disease and Ulcerative Colitis. The master complaint alleges that Hoffman-LaRoche created a defective product and negligently marketed that product to consumers.

Furthermore, the complaint alleges that the company failed to warn consumers about the serious side effects associated with Accutane use; inflammatory bowel disease, (IBD). The complaint also alleges that Hoffman-LaRoche failed to take the product off the market once the bowel side effects, birth defects and suicide were known.

A master complaint is intended to streamline the legal process generally, and potentially lead to more timely settlements.

Crohns disease and ulcerative colitis are two forms of IBD. Both diseases involve the patient’s digestive tract. Crohns disease can lead to ulcers, incontinence, intestinal blockages, bowel cancer, and removal of the colon and rectum.

The New Jersey court agreed to the Accutane lawsuit mass tort, placing it under the direction of Judge Carol E. Higbee.

Judge Higbee has chosen several lawsuits as bellwether cases. Each Accutane lawsuit identified as a bellwether case will address some of the issues outlined in the master complaint, including whether or not patients were adequately warned about the risks of dangerous side effects like Crohns disease. The bellwether cases will likely set a precedent for future Accutane lawsuit outcomes and settlements.

Click here to visit my website and learn more about Accutane Lawsuits

Comments for this article are closed.